about
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.Quantification of dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation.Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.Neurofilament light chain level is a weak risk factor for the development of MS.Improving automated multiple sclerosis lesion segmentation with a cascaded 3D convolutional neural network approach.Brain networks associated with cognitive and hedonic responses to a meal.Automated tissue segmentation of MR brain images in the presence of white matter lesions.A toolbox for multiple sclerosis lesion segmentation.Predictive value of early brain atrophy on response in patients treated with interferon βAromatase imaging with [N-methyl-11C]vorozole PET in healthy men and women.Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.Evaluating the effect of multiple sclerosis lesions on automatic brain structure segmentation.The effects of aging on dopaminergic neurotransmission: a microPET study of [11C]-raclopride binding in the aged rodent brain.In vivo imaging of brain aromatase in female baboons: [11C]vorozole kinetics and effect of the menstrual cycle.Iterative reconstruction with correction of the spatially variant fan-beam collimator response in neurotransmission SPET imaging.[(11)C]-DASB microPET imaging in the aged rat: frontal and meso-thalamic increases in serotonin transporter binding.6-[18F]Fluoro-A-85380, a new PET tracer for the nicotinic acetylcholine receptor: studies in the human brain and in vivo demonstration of specific binding in white matter.In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography.Synthesis and evaluation of inhaled [11C]butane and intravenously injected [11C]acetone as potential radiotracers for studying inhalant abuse.A supervised framework with intensity subtraction and deformation field features for the detection of new T2-w lesions in multiple sclerosis.Depressed glucose consumption at reperfusion following brain ischemia does not correlate with mitochondrial dysfunction and development of infarction: an in vivo positron emission tomography study.Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation.In vivo molecular imaging of the GABA/benzodiazepine receptor complex in the aged rat brain.Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.Simultaneous dual-tracer PET imaging of the rat brain and its application in the study of cerebral ischemia.Evaluation of hypoxic tissue dynamics with 18F-FMISO PET in a rat model of permanent cerebral ischemia.Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats.Measurement of Cortical Thickness and Volume of Subcortical Structures in Multiple Sclerosis: Agreement between 2D Spin-Echo and 3D MPRAGE T1-Weighted Images.Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields.Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas.Brain atrophy in natalizumab-treated patients: A 3-year follow-up.Grey matter atrophy is associated with disability increase in natalizumab-treated patients.Positron emission tomographic imaging of the cannabinoid type 1 receptor system with [¹¹C]OMAR ([¹¹C]JHU75528): improvements in image quantification using wild-type and knockout mice.Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics.Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.Study of the point spread function (PSF) for 123I SPECT imaging using Monte Carlo simulation.Assessment of SPM in perfusion brain SPECT studies. A numerical simulation study using bootstrap resampling methods.Erythrocytes labeled with [(18) F]SFB as an alternative to radioactive CO for quantification of blood volume with PET.
P50
Q31042055-17BD4E37-4EB0-4765-BEA6-6FE2224AAE88Q31149385-EB3B39C5-491F-4C48-A33D-0AB263A8AE15Q36043389-69EA4430-F329-4AD4-97B4-6303247BFD86Q36341251-692BA586-7E16-408C-B9E8-2C29EAC77075Q37265143-B8383661-9624-4B5F-85A7-D1B2C87A83EEQ38824106-BCBBB495-8ACC-4F14-94FF-92126B11677DQ39302678-857130BC-9643-4A16-9DD9-30A403B35EE8Q39420084-A54978C2-6E4C-47FD-8C23-04387BBACD07Q40676968-72DB7815-2940-465C-8065-CAFE81935EFAQ41197913-02DFE8D9-3FAC-429F-A8BE-C6D727C57E9DQ41385183-F7027463-879E-42D2-BEC7-244A98EEDB30Q41999269-6DE2B7BA-615C-48C2-AC9B-9B6881B2FC19Q42269985-4911DE1A-5BD6-451C-84A7-C72C0AABAFB1Q42862249-99F12F39-506B-4D75-9A05-B1E1D49CC68EQ44419074-B3464533-C533-4D36-A0F8-EF6D3E12333DQ44502908-76CA06D1-6A37-4868-AFD9-361C98A9AD56Q44773859-AD073095-AE24-4CD4-884B-FBC45D2B3052Q44965405-A1E15599-CFCC-4A2C-B256-A0E8202E26C9Q45084871-B0CE434C-AE4A-4C8C-99B3-9E2E8B113B21Q45274933-D20C556A-93D3-40C5-94E6-19F8B9F59235Q45943006-473F402D-4CA0-45E3-83AF-948A316F4799Q46012289-DFA05F6A-6FB7-4114-9345-6A5EEC35FC59Q46391580-4F25D29D-17EB-4D2C-8E40-DA58E7C5D16BQ46487166-20287FCD-29A6-4DBF-BA0C-1EB81565F24DQ46569941-C65AA026-5AAB-4370-9B86-3ADCD5783DABQ48115794-3784617E-9AB3-4317-8147-AAC211C24888Q48140057-7E11A742-7CF8-4010-AEE2-9D3F26E91E5EQ48143686-9AFD3D82-3E29-4C2D-B9F6-2674A453A9E4Q48189477-0D133E9D-5BFC-488F-9FA2-CBC0C983B687Q48199092-5C991080-4BAD-494B-9DC8-DF791737FD3EQ48206411-32A42BEE-4F74-4C0D-9165-BBC0AE5EABD2Q48353619-284692FD-5A96-4750-B883-86CB30FE546EQ48457699-D1B10F19-92E8-49E3-86F2-7BC8E0457320Q48651177-0767101F-93FC-497E-917A-C3CBF7EA8ED8Q48746224-BD8E74C1-EA61-4D14-96B5-5E145B370B63Q48865505-B39C3A90-8D6C-47FB-8FE7-063CA2F0D822Q48926070-7F19F266-6D1F-4722-AEDC-A7CFEE9D273FQ48960735-D915EC4D-BBFC-4B7F-BC6A-73E8038D2FD9Q49129893-5A2CA76C-F44D-43E9-9BA6-CA88D69C23EFQ50491974-D4FD69EA-5D3B-4219-B9A7-305F469A318B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Deborah Pareto
@ast
Deborah Pareto
@en
Deborah Pareto
@es
Deborah Pareto
@nl
Deborah Pareto
@sl
type
label
Deborah Pareto
@ast
Deborah Pareto
@en
Deborah Pareto
@es
Deborah Pareto
@nl
Deborah Pareto
@sl
prefLabel
Deborah Pareto
@ast
Deborah Pareto
@en
Deborah Pareto
@es
Deborah Pareto
@nl
Deborah Pareto
@sl
P106
P21
P31
P496
0000-0001-7356-3769